Research Roundup

OFFICIAL PUBLICATION OF

by its subsidiary APPco

Debbie Rigby 18/07/2017

Debbie Rigby takes a look at the latest in research news Efficacy and safety of tofacitinib monotherapy, tofacitinib with methotrexate, and adalimumab with methotrexate in patients with rheumatoid arthritis (ORAL Strategy) Tofacitinib is an oral Janus kinase (JAK) inhibitor for the treatment of rheumatoid arthritis. The Oral Rheumatoid Arthritis triaL (ORAL) Strategy aimed to assess

This content is restricted to registered users only. If you have already registered on the AJP website please login below, Or you can Register for free.

Recent Comments
Popular Posts

Should nicotine vaping products go S3?

sad but true indictment of current pharmacy practice. The truth is atm , More is more in pharmacy. There is…

bry mut

Should nicotine vaping products go S3?

Can't wait for selling Vapes to be part of the up-selling KPIs.

Evan Nickols

Should nicotine vaping products go S3?

Except that is is illegal for the servo to supply the vapes and we are already seeing crack downs on…

(Mary) Kay Dunkley

Transaction fees drive MedAdvisor growth

Funny how business thinks an increase in transaction fees is a good thing.

Leopold Hamulczyk

Research Roundup

Previous Change at the top

Next At-risk travellers prioritise insurance over vaccinations

Clinical tips: Timing!

Clinical tips: Movement disorders

Clinical tips: Worms, Worms, Worms

Intranasal Midazolam for at home use

MENU

Previous Change at the top

Next At-risk travellers prioritise insurance over vaccinations

Related Posts

MENU

Hi there! 👋 Looks like you’re not logged in.